NELA BioDynamics files a 3rd patent (P202230139)

NELA BioDynamics has recently submitted for approval the third patent in its portfolio with number P202230139 at the Spanish Patent and Trademark Office. This patent is based on a new instrument for high-precision milling of the geometry of the femoral neck in primary...

NELA BioDynamics exhibition at the LSI USA ‘22

Last week, NELA BioDynamics participated at the LSI Emerging MedTech Summit held March 15-18, 2022, at Monarch Beach Resort in Dana Point, CA. José Expósito-Ollero, CEO & Founder, presented the company, showcasing NELA patented technology and its benefits to key...

NELA BioDynamics selected for LSI Investor Event

NELA BioDynamics is excited to announce that has been selected by LSI to participate in its annual event LSI Emerging MedTech Summit 2022 from 15-18th March. This event brings together a large number of world-class investors and players from the health sector in Dana...

NELA BioDynamics makes its first steps into the USA

NELA BioDynamics has been accepted into the Octane LaunchPad SBDC accelerator that ranks in the top 5 out of over 900 SBDCs in the United States. Octane is a convening organization of the Southern California technology and medical technology business ecosystem by...

NELA BioDynamics obtained a grant from IVACE

NELA BioDynamics obtained a grant from the Valencian Institute of Business Competitiveness (IVACE) through the call CREATEC-CV-2020. This call is oriented to supporting the development of innovative & technology-based companies whose activities are based on the...